個人化醫療中的奈米材料：全球市場

個人化醫療中奈米材料的全球市場預計將從2023年的 3,467 億美元成長到年終的5,920 億美元，預測期內年複合成長率為 11.3%。

依產品類型分類，蛋白質部門預計將從2023年的1,128億美元成長到年終的2,032億美元，同期年複合成長率為12.5%。此外，單株抗體部門預計將從2023年的780億美元成長到年終的1,364億美元，年複合成長率為11.8%。

本報告調查了個人化醫療中奈米材料的全球市場，概述了奈米材料和技術，分析了市場影響因素和市場機會、法律制度、市場規模趨勢和預測，以及按各個細分市場和地區的詳細分析，技術及專利趨勢，ESG 發展，競爭形勢以及主要企業概況等彙整資訊。

目錄

第1章 簡介

• 奈米治療學概述
• 聚合物奈米材料
• 磁性奈米材料
• 二氧化矽基奈米材料
• 碳奈米材料
• 複合奈米材料
• 生物奈米材料：抗體、蛋白質、DNA
• 奈米碳管
• 其他奈米材料
• 多功能奈米材料
• 藥物輸送
• 本研究的目標和目的
• 調查範圍
• 調查方法
• 資訊來源
• 區域分類

第2章 總結/要點

• 市場展望
• 市場洞察

第3章 市場概況

• 市場概況
• 治療診斷與個人化醫療：概述
• 奈米顆粒
• 被動瞄準
• 主動瞄準
• 奈米技術：概述
• 尺寸定義
• 形狀
• 表面積
• 奈米治療藥物輸送
• 體內藥物釋放研究
• 藥用效果
• 前景

第4章 奈米裝置與奈米材料在診斷的應用

• 概述
• 診斷中的分子識別
• 奈米圖案裝置
• 粒子
• 奈米碳管
• 奈米碳管作為免疫活性化合物、蛋白質和遺傳物質的載體
• 癌症光熱治療
• 用於其他治療應用的奈米碳管
• 富勒烯C60
• C60毒性
• 攝取和生物分佈
• 抗氧化特性
• 包涵體
• 磁振造影
• 放射性核種
• 動態療法
• DNA光裂解
• 癌症
• 抑制酵素、病毒和細菌
• 藥物和基因傳遞
• 磁性奈米顆粒
• 中暑
• 磁選
• 成像和交付
• 腦腫瘤遞送
• 攝護腺癌
• 膀胱腫瘤
• 量子點
• 適配體綴合的奈米粒子
• 基於奈米粒子的生物條碼
• 多重樹枝狀聚合物
• 表面增強拉曼光譜
• 診斷及醫療設備業
• 多功能奈米粒子
• 聚合物奈米顆粒在癌症治療的應用
• 用於癌症成像的聚合物成像探針
• 量子點在癌症影像和治療的應用
• 動態療法和成像中的量子點
• 用於癌症成像和治療的多功能成像奈米粒子
• 用於磁振造影和基因傳遞的磁性奈米粒子
• 用於癌症成像和治療的多功能磁性聚合物混合
• 用於光熱治療的金奈米粒子
• 金奈米殼
• 金奈米棒
• 用於光熱治療和成像的磁性金奈米殼
• 結論/未來趨勢

第5章 以奈米材料的醫療器材相關感染治療

• 醫療器材相關感染及其治療
• 導管相關感染疾病
• 軟組織植入相關感染疾病
• 生物膜形成
• 預防及治療醫療器材相關感染的常用方法
• 奈米材料在醫療上的應用
• 奈米材料在個人化醫療的應用
• 抗菌奈米材料
• 奈米銀
• 氧化鋅
• 鐵和氧化鐵奈米顆粒
• 氧化鈦
• 奈米碳管和富勒烯
• 幾丁聚醣
• 考慮細胞毒性

第6章 生物醫用奈米粒子產品

• CMO
• IT
• 奈米顆粒藥物傳輸系統和產品
• 奈米顆粒藥物傳輸系統
• 公司奈米顆粒藥物傳輸管道

第7章 治療/診斷配套套件

第8章 市場動態

• 市場促進因素
• 市場抑制因素
• 市場機會

第9章 法規環境

第10章 COVID-19 對市場的影響

第11章 市場細分：依產品類型

• 市場概況
• 蛋白質
• 單株抗體（mAb）
• 單株抗體治療
• 機制
• 奈米晶體
• 奈米晶體的製造
• 脂質體
• 脂質體的分類與製備
• 超音波
• 擠壓成型
• 凍融脂質體
• 溶劑分散法
• 清潔劑去除法
• 隱形脂質體
• 抗體-脂質體複合物
• 脂質體在醫學和製藥的應用
• 脂質體在寄生蟲和感染疾病的應用
• 脂質體在抗癌治療的應用
• 體外光學成像
• 金奈米載體
• 中暑
• 對比增強劑
• 放射線治療
• 量子點作​​為奈米載體
• 感測光物理特性、藥物傳遞和藥物釋放
• 體外細胞攝取的可視化
• 奈米載體的生物分佈
• 短干擾 RNA 和 DNA 的遞送

第12章 市場區隔：依地區

• 概述
• 北美洲
• 歐洲
• 亞太地區
• 其他地區

第13章 ESG發展

• ESG：簡介
• 環境
• 社會
• 政府
• 行業領導者的永續發展
• 製藥最終用戶的永續性
• 案例分析
• BCC的結語

第14章 新興技術

• 概述
• 當前市場趨勢
• 新技術
• 生物標記
• 深度表現型分析技術
• 數位精準醫療
• 遺傳學
• 健康資訊技術

第15章 專利/管道分析

第16章 併購前景

• 併購分析
• 主要策略聯盟

第17章 競爭形勢

• 概述
• 奈米生物技術和奈米醫藥企業分佈
• 企業市場占有率分析

第18章 公司簡介

• BRISTOL-MYERS SQUIBB
• CAMURUS AB
• CYTIMMUNE SCIENCES
• EISAI
• GILEAD SCIENCES INC.
• IPSEN PHARMA

第19章 附錄：首字母縮略詞

Highlights:

The global market for nanomaterials in personalized medicine is expected to increase from $346.7 billion in 2023 to $592.0 billion by the end of 2028, with a compound annual growth rate (CAGR) of 11.3% during the forecast period of 2023-2028.

Proteins market for nanomaterials in personalized medicine is expected to increase from $112.8 billion in 2023 to $203.2 billion by the end of 2028, with a CAGR of 12.5% during the forecast period of 2023-2028.

Monoclonal antibodies market for nanomaterials in personalized medicine is expected to increase from $78.0 billion in 2023 to $136.4 billion by the end of 2028, with a CAGR of 11.8% during the forecast period of 2023-2028.

Report Scope:

The current report will provide detailed exposure to nanomaterials in the personalized medicine market. This report analyzes the market trends of nanomaterials in personalized medicine with data from 2022, estimates from 2023, and projections of compound annual growth rates through 2028 (forecast period of 2023 to 2028. This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2028 and the market share for key market players.

The scope of the market in this report is segmented into product type and region. The product type of nanomaterials in personalized medicine is further segmented into proteins, monoclonal antibodies, nanocrystals, liposomes, gold nanoparticles, and quantum dots. The regional market analysis of nanomaterials in personalized medicine is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India is covered within the regional segments. For market estimates, data is provided for 2022 as the base year, with an estimate for 2023 and forecast value for 2028.

Report Includes:

• 27 data tables and 50 additional tables
• An overview of the global market for nanomaterials in personalized medicine
• Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
• Discussions of the current and future market potential, and quantification of the market by product type and region
• Description of emerging technologies such as biomarkers, deep phenotyping, digital precision medicine, genetics, and health information technology; and discussion on ESG trends and pharma end user sustainability in the industry
• Details about various terms such as monoclonal antibodies (mAbs), nanocrystals, liposomes, their usage in vaccine production, and discussion on how quantum dots work as nanocarriers
• Insights into advances in nanotechnology by using next-generation vaccines regimes and an overview of the government investments in healthcare sectors
• Coverage of projects funded by the National Human Genome Research Institute (NHGRI) and other private and government investments, and information on Sanofi in-licensed Exscientia's innovative bispecific small molecule candidate
• Assessments of innovations and technological advances, the adoption of precision healthcare, and regulatory scenarios, and market drivers, restraints, and opportunities
• Analysis of the market shares of the key companies and their proprietary technologies, patents, partnerships and alliances and other key strategies
• Company profiles of major players within the industry, including Bristol-Myers Squibb, Eisai, Gilead Sciences Inc., and Ipsen Pharma

Table of Contents

Chapter 1 Introduction

• Overview of Nanotheranostics
• Polymeric Nanomaterials
• Magnetic Nanomaterials
• Silica-Based Nanomaterials
• Carbon Nanomaterials
• Composite Nanomaterials
• Biologic Nanomaterials: Antibody, Proteins and DNA
• Carbon Nanotubes
• Other Nanomaterials
• Multifunctional Nanomaterials
• Drug Delivery
• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• What's New in this Update?
• Methodology
• Information Sources
• Geographic Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Insights

Chapter 3 Market Overview

• Market Overview
• Theranostics and Personalized Medicines Overview
• Nanoparticles
• Passive Targeting
• Active Targeting
• Nanotechnology Overview
• Size Definition
• Shape
• Surface Area
• Nanotheranostic Drug Delivery
• In Vivo Drug-Release Studies
• Drug Efficacy
• Future Perspectives

Chapter 4 Nanodevices and Nanomaterials in Diagnostics

• Overview
• Molecular Recognition in Diagnosis
• Nanopatterned Devices
• Particles
• Carbon Nanotubes
• Carbon Nanotubes as a Carriers of Immunoactive Compounds, Proteins and Genetic Materials
• Cancer Photothermal Therapy
• Carbon Nanotubes for Other Therapeutic Applications
• Fullerene C60
• C60 Toxicity
• Uptake and Biodistribution
• Antioxidant Properties
• Endohedrals
• Magnetic Resonance Imaging
• Radionuclides
• Photodynamic Therapy
• DNA Photocleavage
• Cancer
• Enzymes, Viruses, and Bacteria Inhibition
• Drug and Gene Delivery
• Magnetic Nanoparticles
• Hyperthermia
• Magnetic Separation
• Imaging and Delivery
• Brain Tumor Delivery
• Prostate Cancer
• Bladder Tumors
• Quantum Dots
• Aptamer-Conjugated Nanoparticles
• Nanoparticle-Based Bio-Bar Codes
• Multiplex Dendrimers
• Surface Enhanced Raman Spectroscopy
• Diagnostic and Medical Device Industry
• Multifunctional Nanoparticles
• Polymeric Nanoparticles in Cancer Therapy
• Polymeric-Based Imaging Probes for Cancer Imaging
• Quantum Dots in Cancer Imaging and Therapy
• Quantum Dots in Photodynamic Therapy and Imaging
• Multifunctional Imaging Nanoparticles for Cancer Imaging and Therapy
• Magnetic Nanoparticles for Magnetic Resonance Imaging and Gene Delivery
• Multifunctional Magneto-Polymeric Nanohybrids for Cancer Imaging and Therapy
• Gold Nanoparticles for Photothermal Therapy
• Gold Nanoshells
• Gold Nanorods
• Magnetic Gold Nanoshells for Photothermal Therapy and Imaging
• Conclusion and Future Trends

Chapter 5 Treatments Based on Nanomaterial for Infections Associated with Medical Devices

• Infections Associated with Medical Devices and Their Treatments
• Catheter-Associated Infections
• Soft-Tissue-Implant-Associated Infections
• Biofilm Formation
• Common Methods for Preventing and Treating Medical Device-Associated Infections
• Nanomaterials in Medical Applications
• Nanomaterials in Personalized Medicine
• Antimicrobial Nanomaterials
• Silver Nanoparticles
• Zinc Oxide
• Iron and Iron-Oxide Nanoparticles
• Titanium Oxide
• Carbon Nanotubes and Fullerenes
• Chitosan
• Cytotoxicity Consideration

Chapter 6 Biomedical Nanoparticle Products

• Introduction
• Contract Manufacturing Organizations
• Information Technology
• Nanoparticle Drug Delivery Systems and Products
• Nanoparticle Drug Delivery Systems
• Company Pipelines for Nanoparticle Drug Delivery

Chapter 7 Therapeutic and Diagnostic Companion Kits

• Introduction

Chapter 8 Market Dynamics

• Market Drivers
• Rising Prevalence of Chronic Diseases Globally
• Rising Cancer Cases Globally
• Cancer Mortality
• Increasing Number of Diabetes Cases Worldwide
• Rising Worldwide Cases of Hypercholesterolemia
• Other major drivers in the personalized medicine market are:
• Market Restraints
• Challenges with Personalized Medicine
• Market Opportunities
• Nanodrug Delivery for the Treatment of Neurological Disorders
• Increasing Government Investment in Healthcare Sectors
• Rising Healthcare Costs
• Consumer Expectations

Chapter 9 Regulatory Landscape

• Overview
• Physicochemical Properties of Nanoproducts Differ Compared to Their Larger Counterparts
• Regulatory Issues in Nanotechnology
• Nanomedicines in the Pharmaceutical Market
• Market Access and Pharmacoeconomics

Chapter 10 Impact of COVID-19 on the Market

• Overview
• Structure of COVID-19 and Penetration
• COVID-19 Crisis
• Impact of COVID-19 on Nanomaterials in Personalized Medicine
• Novel Coronavirus Relying on Various Approaches
• Challenges in Vaccine Disruptions
• Components and Methods in the Design of a Vaccine
• Antigens
• Adjuvants
• Nanoparticles/Nanocarriers
• Devices
• Next-Generation Vaccines Enabled Through Advances in Nanotechnology
• Conclusions Regarding Use of Nanotechnology to Combat COVID-19
• COVID-19 Measures

Chapter 11 Market Breakdown by Product Type

• Market Overview
• Proteins
• Monoclonal Antibodies (mAbs)
• Monoclonal Antibody Therapy
• Mechanism
• Nanocrystals
• Nanocrystals Fabrication
• Liposomes
• Liposome Classification and Preparation
• Sonication
• Extrusion
• Freeze-Thawed Liposomes
• Solvent Dispersion Method
• Detergent-Removal Method
• Stealth Liposome
• Antibody-Liposome Conjugate
• Liposome Application in Medicine and Pharmacology
• Liposomes in Parasite Diseases and Infections
• Liposomes in Anticancer Therapies
• In Vitro Optical Imaging
• Gold Nanocarrier
• Hyperthermia
• Contrast Enhancers
• Radiotherapy
• Quantum Dots as Nanocarriers
• Photophysical Properties, Drug-Delivery and Drug-Release Sensing
• Visualizing Intracellular Uptake In Vitro
• Nanocarrier Biodistribution In Vivo
• Short Interfering RNA and DNA delivery

Chapter 12 Market Breakdown by Region

• Overview
• North America
• U.S. Market Size and Forecast
• Canada Market Size and Forecast
• Europe
• Germany Market Size and Forecast
• U.K. Market Size and Forecast
• France Market Size and Forecast
• Italy Market Size and Forecast
• Spain Market Size and Forecast
• Rest of European Market Size and Forecast
• Asia-Pacific
• China Market Size and Forecast
• Japan Market Size and Forecast
• India Market Size and Forecast
• South Korea Market Size and Forecast
• Rest of Asia-Pacific Market Size and Forecast
• Rest of the World
• South America Market Size and Forecast
• Middle East and Africa Market Size and Forecast

Chapter 13 ESG Development

• Introduction to ESG
• Environmental
• Social
• Government
• The Sustainability of Major Companies in the Industry
• Pharma End User Sustainability in the Industry
• Case Study
• Concluding Remarks from BCC

Chapter 14 Emerging Technologies

• Overview
• Current Market Trends
• Emerging Technologies
• Biomarkers
• Deep Phenotyping Technologies
• Digital Precision Medicine
• Genetics
• Health Information Technology

Chapter 15 Patents and Pipeline Analysis

• Overview
• Patent Analysis
• Pipeline Analysis

Chapter 16 M&A Outlook

• M&A Analysis
• Major Strategic Alliances

Chapter 17 Competitive Landscape

• Overview
• Distribution of Nanobiotechnology and Nanomedicine Companies
• Company Share Analysis

Chapter 18 Company Profiles

• BRISTOL-MYERS SQUIBB
• CAMURUS AB
• CYTIMMUNE SCIENCES
• EISAI
• GILEAD SCIENCES INC.
• IPSEN PHARMA

Chapter 19 Appendix: Acronyms

List of Tables

• Summary Table : Global Market for Nanomaterials in Personalized Medicine, by Product Type, Through 2028

Table A : Types of Nanomaterials

Table B : Major Nanomaterial Applications in Personalized Medicine

• Table 1 : Therapies with Diagnostic Companion Kits
• Table 2 : Nanoparticle Systems Approved for Drug Delivery
• Table 3 : Imaging Modalities Used in Theranostics Nanodevices
• Table 4 : Nanoparticles Contrast Media Used for In Vivo Diagnostic Imaging
• Table 5 : Major Players in Nanoparticle Drug Development and Formulation Market
• Table 6 : Nanoparticles Used in Drug Delivery Systems
• Table 7 : List of Marketed Products Used in Different Nanotechnology-Based Techniques
• Table 8 : Major Companies in the Market for Nanoparticle Drug Development and Formulation
• Table 9 : Company Pipelines for Cardiovascular Nanoparticle Drugs
• Table 10 : Company Pipelines for CNS Disease Nanoparticle Drugs
• Table 11 : Company Pipelines for GI Disease Nanoparticle Drugs
• Table 12 : Company Pipelines for Infectious Disease Nanoparticle Drugs
• Table 13 : Company Pipelines for Cancer Nanoparticle Drugs
• Table 14 : Company Pipelines for Ophthalmic Nanoparticle Drugs
• Table 15 : Company Pipelines for Autoimmune Disease Nanoparticle Drugs
• Table 16 : Global Prevalence of Breast Cancer, by Country/Region, Through 2025
• Table 17 : Global Epidemiology of Colorectal Cancer, by Region, Through 2030
• Table 18 : Global Deaths, by Various Cancer Types, Through 2030
• Table 19 : Global Death Share, by Various Cancer Types, 2021
• Table 20 : Global Diabetes Prevalence, Estimates and Projections, 2019-2045
• Table 21 : Cases of Diabetes Worldwide, by Type, 2019
• Table 22 : Global Prevalence of Diabetes, by Type, Through 2040
• Table 23 : Global Totals of Angina Pectoris and Stroke Survivors, Through 2030
• Table 24 : Global Incidence and Prevalence of all Stroke Types, 2019
• Table 25 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
• Table 26 : Global Market for Nanomaterials in Personalized Medicine, by Product Type, Through 2028
• Table 27 : Products of Non-monoclonal Antibody Proteins
• Table 28 : Global Market for Proteins in Personalized Medicine, by Region, Through 2028
• Table 29 : Major Companies in the Market for Monoclonal Antibodies
• Table 30 : Indications of Monoclonal Antibody Products
• Table 31 : Global Market for Monoclonal Antibodies in Personalized Medicine, by Region, Through 2028
• Table 32 : Properties of Nanocrystals
• Table 33 : Nanocrystal Drug Features
• Table 34 : Nanocrystal Fabrication Methods
• Table 35 : Nanocrystal Drugs Currently on the Market
• Table 36 : Global Market for Nanocrystals in Personalized Medicine, by Region, Through 2028
• Table 37 : Liposome Advantages
• Table 38 : Liposome-Based Drugs
• Table 39 : Major Companies in the Liposomes Market
• Table 40 : Global Market for Liposomes in Personalized Medicine, by Region, Through 2028
• Table 41 : Global Market for Gold Nanoparticles in Personalized Medicine, Through 2028
• Table 42 : Global Market for Quantum Dots in Personalized Medicine, Through 2028
• Table 43 : Global Market for Nanomaterials in Personalized Medicine, by Region, Through 2028
• Table 44 : Diabetes Estimates in North America, by Country, 2000-2045
• Table 45 : Influenza Disease Burden in U.S., by Age Group, 2019 and 2020 Influenza Season
• Table 46 : North America Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
• Table 47 : Diabetes Estimates in Europe, by Country, 2000-2045
• Table 48 : European Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
• Table 49 : Tuberculosis Burden of Asian Countries, by Country, 2019
• Table 50 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000-2045
• Table 51 : Asia-Pacific Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
• Table 52 : Diabetes Estimates in the RoW, by Country, 2000-2045
• Table 53 : Estimation of New Cancer Cases in Africa, by Cancer Type, 2020 and 2024
• Table 54 : Rest of the World Market for Nanomaterials in Personalized Medicine, by Region, Through 2028
• Table 55 : Key Focus Areas in ESG Metrics
• Table 56 : ESG Rankings for Select Nanomaterials Personalized Medicine Companies, 2023
• Table 57 : Examples of Nanomaterials Used in Theranostics
• Table 58 : Global Patents on Nanotechnologies, by Country, 2017-2020
• Table 59 : Number of Patents, by Technology, 2001-2021*
• Table 60 : Protein Drugs
• Table 61 : Nanoparticle Systems Approved for Drug Delivery
• Table 62 : Major Strategic Alliances, 2018-2023
• Table 63 : Major Players in the Nanoparticles Drug Field
• Table 64 : Global Distribution of Nanobiotechnology and Nanomedicine Companies
• Table 65 : Bristol-Myers Squibb: Financial Performance, 2021 and 2022
• Table 66 : Bristol-Myers Squibb: Key Developments, 2019
• Table 67 : Camurus AB: Financial Performance, 2021 and 2022
• Table 68 : Camurus AB: Key Developments, 2019
• Table 69 : Cytimmune Sciences: News, 2021
• Table 70 : Eisai: Financial Performance, 2021 and 2022
• Table 71 : Eisai: News, 2021
• Table 72 : Gilead Sciences Inc.: Financial Performance, 2021 and 2022
• Table 73 : Ipsen Pharma: Financial performance, 2021 and 2022
• Table 74 : Acronyms Used in This Report

List of Figures

Figure A : Types of Nanomedicine Composed of Different Types of Materials

• Summary Figure : Global Market Shares of Nanomaterials in Personalized Medicine, by Product Type, 2022
• Figure 1 : Types of Nanomedicines Composed of Different Types of Materials
• Figure 2 : Nanoparticles Used in Personalized Medicine
• Figure 3 : Nanotechnology Used in Personalized Medicine
• Figure 4 : Shares of New Cancer Cases, Women, 2020
• Figure 5 : Shares of New Cancer Cases, Men, 2020
• Figure 6 : Global Prevalence of Breast Cancer, by Country/Region, 2015-2025
• Figure 7 : Global Epidemiology of Colorectal Cancer, by Region, 2000-2030
• Figure 8 : Global Deaths, by Various Cancer Types, 2000-2030
• Figure 9 : Global Death Share, by Various Cancer Types, 2021
• Figure 10 : Cases of Diabetes Worldwide, by Type, 2019
• Figure 11 : Global Prevalence of Diabetes, by Type, 2018 and 2040
• Figure 12 : Protein Nanoparticle Fabrication and Performance Factors
• Figure 13 : Global Market for Proteins in Personalized Medicine, 2020-2028
• Figure 14 : Global Market for Monoclonal Antibodies in Personalized Medicine, 2020-2028
• Figure 15 : Global Market for Nanocrystals in Personalized Medicine, 2020-2028
• Figure 16 : Application of Liposomes in the Drug Delivery Arena
• Figure 17 : Global Market for Liposomes in Personalized Medicine, 2020-2028
• Figure 18 : Global Market for Gold Nanoparticles in Personalized Medicine, 2020-2028
• Figure 19 : Global Market for Quantum Dots in Personalized Medicine, 2020-2028
• Figure 20 : Global Market Shares of Nanomaterials in Personalized Medicine, by Region, 2022
• Figure 21 : North America Market for Nanomaterials in Personalized Medicine, by Country, 2020-2028
• Figure 22 : Cancer Diagnosis Share in Europe, by Gender, 2020
• Figure 23 : European Market for Nanomaterials in Personalized Medicine, by Country, 2020-2028
• Figure 24 : Asia-Pacific Market for Nanomaterials in Personalized Medicine, by Country, 2020-2028
• Figure 25 : Rest of the World Market for Nanomaterials in Personalized Medicine, by Region, 2020-2028
• Figure 26 : How a Strong ESG Proposition Benefits Businesses
• Figure 27 : ESG-Adoption Level Across All the Industries, 2021 and 2022
• Figure 28 : The Ten Business Sustainability Trends Identified for 2022
• Figure 29 : Key Sustainable Practices Being Implemented in Research Laboratories
• Figure 30 : Emerging Technologies in the Nanomaterials in Personalized Medicine Market
• Figure 31 : Global Market Shares of Nanoparticles in Personalized Medicine, by Company, 2022
• Figure 32 : Bristol-Myers Squibb: Financial Performance, 2021 and 2022
• Figure 33 : Bristol-Myers Squibb: Revenue Share, by Country/Region, 2022
• Figure 34 : Camurus AB: Financial Performance, 2021 and 2022
• Figure 35 : Camurus AB: Revenue Share, by Country/Region, 2022
• Figure 36 : Eisai: Financial Performance, 2021 and 2022
• Figure 37 : Eisai: Revenue Share, by Country/Region, 2022
• Figure 38 : Gilead Sciences Inc.: Financial Performance, 2021 and 2022
• Figure 39 : Gilead Sciences Inc.: Revenue Share, by Country/Region, 2022
• Figure 40 : Ipsen Pharma: Financial Performance, 2021 and 2022
• Figure 41 : Ipsen Pharma: Revenue Share, by Segment, 2022
• Figure 42 : Ipsen Pharma: Revenue Share, by Country/Region, 2022